MIS-C Research

This information was reviewed and approved by Donald Y M Leung, PhD, MD, Pamela L. Zeitlin, MD, MPhil, PhD (5/26/2020).

Research of MIS-C at National Jewish Health

Investigators at National Jewish Health are collaborating with University of Iowa. The researchers are assessing whether toxins (superantigens) producing bacteria may be contributing to the features of systemic inflammation and vascular inflammation in this syndrome. Identification of microbial superantigens, as a cause of multisystem-inflammatory syndrome in children, suggest the possibility that these children may benefit from high-dose intravenous immunoglobulin therapy.

Clinical Trials

For more than 100 years, National Jewish Health has been committed to finding new treatments and cures for diseases. Search our clinical trials.